Susanna Park, M.D., Ph.D.

Susanna Soon-Chun Park, M.D., Ph.D.



Vitreoretinal Surgery


  • Director of Vitreoretinal Fellowship
  • Director of Retina Service
  • Professor, Department of Ophthalmology & Vision Science


To see if Susanna Soon-Chun Park is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Lawrence J. Ellison Ambulatory Care Center

4860 Y St., Suite 2400
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Clinic Fax: 916-734-6197
Physician Referrals: 800-4-UCDAVIS (800-482-3284)

Philosophy of Care

Dr. Park is committed to providing the best and latest treatments for her patients with retinal disorders. She believes this is best achieved by a combination of an excellent medical support teach, latest diagnostic instruments and thorough patient education. As such, Dr. Park and her team are readily available to answer any questions or concerns from her patients.

Clinical Interests

Dr. Park is vitreo-retinal specialist who provides surgical and medical therapies for various retinal disorders, including macular degeneration, diabetic retinopathy, macular holes or puckers, and retinal detachment. She also has expertise in ocular oncology and treats patients with intraocular tumors. She offers proton beam irradiation for ocular melanoma and performs various eye therapies for retinoblastoma.

Research/Academic Interests

Dr. Park's research focuses on developing novel therapies for retinal disorders through translational and clinical research. Her research includes exploring the use of stem cells for retinal regenerative therapy. She also uses of the latest retinal imaging tools to study retinal disorders and effects of therapies.


Vitreo-Retinal Disease and Oncology

Center/Program Affiliation

Eye Center


M.D., Yale University School of Medicine, New Haven CT 1988

Ph.D., Pharmacology, Yale University, New Haven CT 1988

B.S., University of Hawaii, Manoa, Honolulu HI 1981

Internship: Internal Medicine, Hospital of St. Raphael; Yale School of Medicine, New Haven CT 1988-1989


Ophthalmology, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston MA 1989-1992


Vitreoretinal Surgery, Massachusetts Eye & Ear Infirmary, Harvard Medical School, Boston MA 1992-1994

Board Certifications

American Board of Ophthalmology, 2013

Professional Memberships

American Academy of Ophthalmology

American Society of Retinal Specialists

Association for Research in Vision & Ophthalmology

Macula Society

Retina Society

Society of Heed Fellows in Ophthalmology

Women in Ophthalmology

Women in Retina

Honors and Awards

Best Doctors, Sacramento Magazine, 2011, 2012, 2015

Best Doctors in America (Best Doctors, Inc), 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020

Joan Oettinger Memorial Award for Excellence in Cancer Research, UC Davis, 2011

Ophthalmology Resident Faculty Teaching Award (UC Davis), 2010, 2015

Senior Honor Award, American Society of Retinal Specialists, 2010

Achievement Award, American Academy of Ophthalmology, 2009

Honor Award, American Society of Retinal Specialists, 2008

Research to Prevent Blindness Career Development Award, 1994, 1995, 1996, 1997, 1998

Heed Foundation Fellowship Award, 1992

Select Recent Publications

Singh MS, Park SS, Albini TA, Canto-Soler MV, Klassen H, MacLaren RE, Takahashi M, Nagiel A, Schwartz SD, Bharti K. Retinal stem cell transplantation: Balancing safety and potential. Prog Retin Eye Res. 2020 Mar;75:100779. doi:10.1016/j.preteyeres.2019.100779. Epub 2019 Sep 5. PMID:31494256.

Mukkamala LK, Mishra K, Daftari I, Moshiri A, Park SS. Phase I/II randomized study of proton beam with anti-VEGF for exudative age-related macular degeneration: long-term results. Eye (Lond). 2020 Feb 13. doi:10.1038/s41433-020-0807-2. Epub ahead of print. PMID:32055016.

Yazdanyar A, Zhang P, Dolf C, Smit-McBride Z, Cary W, Nolta JA, Zawadzki RJ, Marsh-Armstrong N, Park SS. Effects of intravitreal injection of human CD34+ bone marrow stem cells in a murine model of diabetic retinopathy. Exp Eye Res. 2020 Jan;190:107865. doi:10.1016/j.exer.2019.107865. Epub 2019 Nov 1. PMID:31682846.

Lu JE, Welch RJ, Mishra KK, Daftari IK, Park SS. Ultrasonography and transillumination for uveal melanoma localisation in proton beam treatment planning. Eye (Lond). 2019 Dec;33(12):1904-1910. doi:10.1038/s41433-019-0512-1. Epub 2019 Jul 5. PMID:31278380.

Emami-Naeini P, Vuong VS, Tran S, Morse LS, Moshiri A, Park SS, Yiu G. Outcomes of Pneumatic Retinopexy performed by Vitreoretinal Fellows. Retina. 2019 Jan;39(1):186-192. doi:10.1097/IAE.0000000000001932. PMID:29135800.

Moisseiev E, Anderson JD, Oltjen S, Goswami M, Zawadzki RJ, Nolta JA, Park SS. Protective Effect of Intravitreal Administration of Exosomes Derived from Mesenchymal Stem Cells on Retinal Ischemia. Curr Eye Res. 2017 Oct;42(10):1358-1367. doi:10.1080/02713683.2017.1319491. Epub 2017 Jun 21. PMID:28636406.

Osmanovic S, Moisseiev E, Mishra KK, Daftari I, Moshiri A, Morse L, Park SS. Phase I/II Randomized Study of Proton Beam with Anti-Vascular Endothelial Growth Factor for Exudative Age-Related Macular Degeneration: One-Year Results. Ophthalmol Retina. 2017 May-Jun;1(3):217-226. doi:10.1016/j.oret.2016.11.003. Epub 2016 Dec 28. PMID:31047424.

Park SS, Moisseiev E, Bauer G, Anderson JD, Grant MB, Zam A, Zawadzki RJ, Werner JS, Nolta JA. Advances in bone marrow stem cell therapy for retinal dysfunction. Prog Retin Eye Res. 2017 Jan;56:148-165. doi:10.1016/j.preteyeres.2016.10.002. Epub 2016 Oct 23. PMID:27784628.

Gupta MP, Coombs P, Prockop SE, Hasan AA, Doubrovina E, O'Reilly RJ, Cohen SH, Park SS, Kiss S. Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion. Ophthalmic Surg Lasers Imaging Retina. 2015 Jan;46(1):80-2. doi:10.3928/23258160-20150101-14. PMID:25559515.

Park SS. Cell Therapy Applications for Retinal Vascular Diseases: Diabetic Retinopathy and Retinal Vein Occlusion. Invest Ophthalmol Vis Sci. 2016 Apr 1;57(5):ORSFj1-ORSFj10. doi:10.1167/iovs.15-17594. PMID:27116667.